Nightingale Health Oyj
NGHLF
$1.75
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 35.54% | 20.95% | 7.84% | 12.31% | 15.72% |
| Total Other Revenue | -- | -- | -- | 1.45% | -- |
| Total Revenue | 35.54% | 20.95% | 7.84% | 12.31% | 15.72% |
| Cost of Revenue | 52.46% | 92.27% | 154.44% | 65.07% | 1.62% |
| Gross Profit | 30.14% | 4.27% | -16.46% | -0.81% | 21.09% |
| SG&A Expenses | -10.24% | -7.08% | -3.70% | 11.28% | 26.70% |
| Depreciation & Amortization | 15.41% | 20.20% | 25.78% | 31.54% | 35.34% |
| Other Operating Expenses | -1.57% | -12.74% | -22.22% | -13.21% | -4.97% |
| Total Operating Expenses | 2.46% | 3.29% | 4.24% | 12.51% | 19.42% |
| Operating Income | 3.86% | 0.38% | -3.43% | -12.55% | -20.15% |
| Income Before Tax | 5.28% | 3.18% | 0.90% | 0.50% | 2.56% |
| Income Tax Expenses | 116.67% | 293.33% | 922.58% | 826.14% | 216.55% |
| Earnings from Continuing Operations | 5.08% | 2.85% | 0.45% | 0.12% | 2.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.08% | 2.85% | 0.45% | 0.12% | 2.26% |
| EBIT | 3.86% | 0.38% | -3.43% | -12.55% | -20.15% |
| EBITDA | 5.77% | 9.16% | 12.70% | -3.97% | -20.78% |
| EPS Basic | 5.09% | 2.87% | 0.48% | -1.30% | -0.56% |
| Normalized Basic EPS | 5.06% | 3.06% | 0.92% | -8.16% | -15.80% |
| EPS Diluted | 5.09% | 2.87% | 0.48% | -1.30% | -0.56% |
| Normalized Diluted EPS | 5.06% | 3.06% | 0.92% | -8.16% | -15.80% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | -1.28% | -2.53% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | -1.28% | -2.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |